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Abstract
A mouse model with compromised mitochondrial fatty acid synthesis has been engineered in order to assess the role of this
pathway in mitochondrial function and overall health. Reduction in the expression of mitochondrial malonyl CoA-acyl carrier
protein transacylase, a key enzyme in the pathway encoded by the nuclear Mcat gene, was achieved to varying extents in all
examined tissues employing tamoxifen-inducible Cre-lox technology. Although affected mice consumed more food than
control animals, they failed to gain weight, were less physically active, suffered from loss of white adipose tissue, reduced
muscle strength, kyphosis, alopecia, hypothermia and shortened lifespan. The Mcat-deficient phenotype is attributed
primarily to reduced synthesis, in several tissues, of the octanoyl precursors required for the posttranslational lipoylation of
pyruvate and a-ketoglutarate dehydrogenase complexes, resulting in diminished capacity of the citric acid cycle and
disruption of energy metabolism. The presence of an alternative lipoylation pathway that utilizes exogenous free lipoate
appears restricted to liver and alone is insufficient for preservation of normal energy metabolism. Thus, de novo synthesis of
precursors for the protein lipoylation pathway plays a vital role in maintenance of mitochondrial function and overall vigor.
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Introduction
According to the United Mitochondrial Disease Foundation,
each year in the United States, as many as 4,000 children are born
who will develop a mitochondrial disease by age 10. On the other
hand, many patients suffer symptoms for years before they are
accurately diagnosed and some mitochondrial defects manifest
only in adults as diseases of aging. Because mitochondria perform
many different functions in addition to ATP synthesis, there likely
are hundreds of diseases that can result from mitochondrial
defects, each disorder producing a spectrum of abnormalities that
can be confusing to diagnose [1,2]. One of the difficulties in
unraveling the etiology of mitochondrial disorders has been that
the roles of many of the ,1500 mitochondrial proteins are poorly
understood and mutations in different genes, encoded in either the
mitochondrial or nuclear genomes, can lead to similar diseases.
Only recently has it become clear that human mitochondria
contain their own unique system for synthesizing fatty acids de
novo that is encoded by nuclear genes [3,4,5,6,7,8]. These genes
encode a suite of discrete individual proteins, termed type II fatty
acid synthase, that is quite distinct from the megasynthase complex
responsible for de novo fatty acid synthesis in the cytosolic
compartment, the type I fatty acid synthase, in which the
individual enzymes are covalently linked. In vitro studies [9,10]
have revealed that the major product of the mitochondrial
pathway is an octanoyl moiety that can be utilized as a precursor
for the formation of lipoyl moieties that are utilized for the
posttranslation modification of key mitochondrial proteins that
constitute the lipoamide subproteome: the E2 subunits of the
pyruvate (PDC), a-ketoglutarate (KDC) and branched-chain a-
ketoacid (BCDC) dehydrogenase complexes and the H-protein
component of the glycine cleavage system (GCS). However,
posttranslational modification of mitochondrial proteins reportedly
also can be expedited using lipoyl moieties derived from
exogenous free lipoic acid [11,12], so the relative physiological
importance of the two lipoylation pathways is unclear. The
objective of this study was to resolve this issue by developing a
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mouse model in which functionality of the mitochondrial pathway
for the de novo synthesis of fatty acyl and lipoyl moieties was
compromised. The target for knockout was the nuclear gene Mcat
that encodes the mitochondrial malonyl CoA-acyl carrier protein
(ACP) transacylase. Mcat catalyzes the transfer of malonyl
moieties from CoA to the phosphopantetheinyl moiety of the acyl
carrier protein (ACP) that is responsible for shuttling reaction
intermediates through the catalytic centers of the enzymes
participating in the pathway [3]. The structure and mechanism
of action of Mcat has been elucidated [13].
Methods
Engineering and genotyping of the knockout mouse
models
A tamoxifen-inducible knockout of the mitochondrial Mcat gene
(GenBank accession number BC099494) was engineered using Cre-
lox technology as follows. The mitochondrial Mcat gene was
initially identified by screening a 129-Ola BAC library and used to
construct a promoterless gene-trap vector [14], essentially as
described earlier [15,16,17]. A modified Mcat gene was engineered
with Lox sites flanking exon 2 to allow eventual excision of exon 2
by a Cre recombinase, resulting in a frame shift in exon 3 and the
production of a severely truncated protein (Fig. S1). The gene-trap
cassette was inserted by homologous recombination so as to
generate an in-frame fusion protein that facilitated expression of
the encoded selectable marker in mouse embryonic stem cells. The
cells were electroporated with linearized DNA, 24 selected
colonies were picked and RNA isolated and analyzed by 59-
RACE. Ten targeted clones were identified and authenticity
confirmed by sequencing and by PCR. Chosen clones were treated
with Flp recombinase in vitro, to excise the Frt-flanked ß-geo
selection cassette, then were injected into C57BL/6J blastocysts
and the resulting male chimeric mice were outcrossed with female
C57BL/6J mice. Germline transmission was found in 66% of the
brown offspring. These mice were intercrossed to generate mice
homozygous for the floxed Mcat allele (HF mice) then crossed with
the inducible-Cre strain B6.Cg-Tg(cre/Esr1)5Amc/J, obtained
from Jackson Labs.
Genotyping
Tissues were digested with proteinase K and DNA was
extracted with phenol:chloro-form:isoamyl alcohol using Phase
Lock GelTM and purified by ethanol precipitation. Mcat and Cre
recombinase genes were characterized using the PCR (Fig. S1).
Animal husbandry and tamoxifen treatment
Mice were housed communally in Thoren Maxi-Miser venti-
lated cages maintained at 7262uF with a 12 h dark, 12 h light
cycle and provided water and Teklad Irradiated Diet 2918 ad
libitum. At 4–6 weeks of age, mice were given five daily
intraperitoneal injections of tamoxifen in corn oil, 0.1 mg per g
body weight. In later experiments, in an attempt to minimize stress
on the animals, tamoxifen was administered orally. These mice
were first fed a reconstituted soy-free diet (Teklad 2020X) for 1
week then transferred to the same diet supplemented with
tamoxifen (0.5 mg per g) for 1 month, after which they were
returned to the standard diet. Both KO and HF mice typically
exhibited transient weight loss during the period of tamoxifen
treatment, presumably because of the anorexic properties of this
compound.
Ethics statement
All procedures were approved by the Children’s Hospital
Oakland Research Institute Animal Care and Use Committee
(Protocol #171) and complied with the U.S. Public Health Service
Policy on Humane Care and Use of Laboratory Animals. The
Children’s Hospital Oakland Research Institute Animal Research
Facility is certified by the Association for the Assessment and
Accreditation of Laboratory Animal Care.
Food consumption
Food consumption was measured by weighing the amount of
food remaining in the food compartment at intervals of 2–3 days
and was normalized for the average body weight of animals in the
cage.
Open field analysis
Open field locomotion [18] was assessed by placing the mouse
in the center of a wooden box 3ft63ft marked in 6 inch squares.
Posture, gait and behavior were observed and activity level was
quantitated by recording the number of squares visited in a 3 min
observation period. Each mouse was tested twice within a 2-week
period and the results averaged.
Rotarod performance
An Economex Rota-Rod (Columbus Instruments) was used in
the acceleration mode, beginning at 4 rpm and accelerating at
0.1 rpm/sec until the mouse fell from the rotating rod. Each
mouse was tested three times at 30 min intervals and the aggregate
time on the rotarod recorded. In the endurance mode, rotation
was fixed at 5 rpm and, in the event of a fall, the mouse was
replaced on the rod.
Grip strength
The peak force a mouse exerted by the front and rear limbs was
measured using a grip strength meter from Columbus Instruments
[19].
Necropsy, histology and blood chemistry
Full necropsies, with histological examination on all major
tissues, and plasma chemistry panel analysis were performed by
the Comparative Pathology Laboratory at the University of
California Davis.
Muscle and liver glycogen and lactate
Muscle and liver glycogen content was measured using a kit
from Biovision, Mountain View, CA. Muscle lactate levels were
measured at the Scripps Center for Metabolomics and Mass
Spectrometry.
Hematology
CBC analysis was performed using a Siemens Advia 120 system.
Red blood cell turnover rate was assessed using flow cytometry to
monitor the disappearance of biotin-labeled red blood cells from
the circulation [20]. Injection of mice via the tail vein with EZ-
Link sulfo-N-hydroxysuccinimide-biotin (Thermo Scientific) re-
sulted in labeling of the entire red blood cell population.
Fecal analysis
Feces from a 24-h collection were lyophilized and pulverized.
Portions of 200 mg were extracted and assayed for protein
content, using the BCA reagent (Pierce), essentially as described
earlier [21]. Lipids were extracted from 300 mg portions of dried
feces with 4 mL chloroform-methanol and quantitated gravimet-
Mouse Mitochondrial Fatty Acid Synthesis Knockout
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rically, essentially as described earlier [22]. Hemoglobin ß was
assayed in protein extracts by Western analysis using anti-mouse
hemoglobin ß antibody (Santa Cruz Biotechnology).
Isolation of Mitochondria
Mitochondria from all tissues, except spleen and bone marrow,
were purified on a five-layer discontinuous iodixanol gradient and
used for both Western analysis and enzyme activity assays. The
purity of mitochondrial fractions prepared in this way was
confirmed by Western analysis using antibodies against a panel
of marker proteins [8]. Mitochondria from mouse spleens were
purified by differential centrifugation [9,10].
Western analysis
Electrophoresis and Western blotting was performed as
described previously [8]. Purified mitochondria were used for all
tissues except bone marrow, for which whole-cell extracts were
used. Sample loading was normalized based on protein content,
usually 5 to 10 mg mitochondrial protein/lane. ß-ketoacyl synthase
(Oxsm) and prohibitin (Phb) immunostaining served as additional
visual loading controls. Each sample was analyzed at least twice,
and only unsaturated images that contained a limited numbers of
black pixels were used for quantification.
Enzyme activities
Activities of PDC and KDC were monitored at 340 nm, 30uC,
in the presence of 0.1% Triton X-100, as described previously [23]
except that components of INT-coupling system and D,L-
carnitine were omitted from the assay.
Overall activity of the mitochondrial fatty acid
biosynthetic pathway
The formation of 14C-octanoyl-ACP, the major product, from
[2-14C] malonate was assayed as described earlier [8].
Respiration of isolated mitochondria
Mitochondria (0.5 mg of protein.mL21), isolated from hind
limb skeletal muscle by differential centrifugation [24], were
incubated at 37uC in air-saturated medium (120 mM KCl, 5 mM
Hepes, 1 mM EGTA, 5 mM KH2PO4, pH 7.2, supplemented
with 0.3% defatted bovine serum albumin), and respiration
monitored with an oxygen electrode. Succinate (5 mM) and
rotenone (2 mM) were used to assay respiration through complex
II. a-Ketoglutarate (7.5 mM) was used to assay respiration
through KDC. Pyruvate (100 mM) and malate (5 mM) were used
to assay respiration through PDC. State 3 respiration was induced
in the presence of substrate by 500 mM ADP, state 4 by the
addition of 1 mg.mL21 oligomycin, and uncoupled respiration was
measured in the presence of carbonyl cyanide p-(tri-fluromethox-
y)phenyl-hydrazone.
Cyanide titrations in isolated mitochondria
Oxygen consumption rates were measured in skeletal muscle
mitochondria isolated from C57BL/6J mice using ascorbate
(1.2 mM) as substrate in the presence of N,N,N9,N9-tetramethyl-
p-phenylenediamine (0.1 mM) to catalyze electron donation to
cytochrome c and complex IV. To eliminate the contribution of
complexes I, III and V, we added antimycin A (20 mM), rotenone
(2 mM) and oligomycin (2 mg.mL21). 4-trifluoromethoxyphenyl-
hydrazone (1 mM) was added to obtain the maximum oxygen
consumption rate. A control oxygen consumption rate was
obtained then the concentration of cyanide needed to inhibit
complex IV was determined, to simulate the degree of cytochrome
a depletion in the KO (40%).
Measurements of cytochrome content
Cytochrome content was determined from difference spectra
(dithionite-reduced minus air-oxidized) on a DW-2 Olis dual-
beam spectrophotometer. Mitochondria (1 mg.mL21) from HF
and KO animals were lysed in CP-1 [25] medium plus 0.5% (w/v)
sodium deoxycholate. Concentrations of cytochromes c, c1, b, and
a were calculated by solving simultaneous equations as described
earlier [26,27]. Wavelength pairs and extinction coefficients were:
cytochrome c 550–535 nm, 25.1 mM21.cm21; cytochrome c1
554–540 nm, 24.1 mM21.cm21; cytochrome b 563–577 nm,
23.2 mM21.cm21; cytochrome a 605–630 nm, 13.1 mM21.cm21.
Statistics
Unless otherwise stated, values are reported as means with
standard deviations. Significance was assessed using two-tailed
independent T-tests.
Results and Discussion
Engineering of knockout mice
Mice homozygous for a modified mitochondrial malonyl-
CoA:ACP acyl transferase gene (Mcat) with lox sites flanking exon
2 (HF mice) were engineered and crossed with mice of the Cre
strain B6.Cg-Tg(cre/Esr1)5Amc/J, which carries a single copy of a
tamoxifen-inducible, Cre-mediated recombination system driven
by the chicken ß-actin promoter/CMV immediate-early enhancer
that facilitates expression in most tissues. Since mice homozygous
for this Cre recombinase gene are not viable, progeny testing
positive for both the Cre recombinase and floxed Mcat genes were
then mated with HF mice. Progeny homozygous for the floxed
Mcat allele that also carried a single copy of the Cre recombinase
gene were identified as knockout (KO) mice. These mice, when
mated with HF mice, produced litters that contained equal
proportions of HF and KO offspring; the HF littermates were used
as control animals for most experiments. Initial genotyping of the
transgenic mice was accomplished by analysis of tail DNA using
the PCR (Fig. 1 A & B). KO mice and HF control mice were
treated with tamoxifen, either via intraperitoneal injection or by
inclusion in the diet. The phenotypes induced in KO mice by the
two routes were indistinguishable. Tamoxifen promoted excision
of exon 2 from the Mcat alleles, with variable efficiency, in all
tissues tested from KO mice but not in those from HF mice (Fig. 1
panels C and D).
Appearance and activity of knockout mice
About 3–4 months after treatment with tamoxifen, the coats of
KO mice lost their normal luster and hair loss became noticeable
(Fig. 1 panels E and F). This condition became progressively
worse, eventually resulting in severe baldness (Fig. 1, panel G).
Skin of the KO mice was noticeably dryer in appearance,
compared to HF controls, and some of the severely affected mice
developed puritus that led to self-inflicted scratch wounds,
necessitating euthanasia (according to institutional guidelines).
The alopecia was universally accompanied by the development of
pronounced kyphosis (Fig. 1, panel H). Both male and female KO
mice treated with tamoxifen failed to gain weight as well as their
littermate HF controls and after 6 months the KO mice began to
lose weight (Fig. 2 panels A and B). The mean survival time for
KO mice not euthanized for experimentation was 293670 days
post-induction (n= 13). Weight loss was not observed in HF
control mice, even up to one year after treatment with tamoxifen
Mouse Mitochondrial Fatty Acid Synthesis Knockout
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Figure 1. Genotype and phenotype of the Mcat knockout mouse. A–D: genotyping by PCR. Mice were screened by PCR analysis of tail DNA,
using the primer pair p5:pEx2, which generates 900 and 300 bp products from the floxed and wild-type alleles, respectively (panels A and D), and
those carrying the floxed Mcat allele were bred to homozygosity (HF). HF mice were mated with Cre mice and bred to homozygosity for the HF Mcat
allele and hemizygosity for the Cre gene, to give the KO genotype. The Cre gene was detected by the unique 100 bp product amplified in the Cre-PCR
reaction, in addition to the 300 bp internal positive control (panel B). After treatment with tamoxifen, deletion of exon 2 was detected in various
tissues from the KO mice, as judged by two independent PCR reactions (panels C and D). Primer pair p5:pEx2 detects the HF allele (900 bp product)
and primer pair p5:p3 generates an 1800 bp product from the HF allele and an 800 bp product from the exon-2-deleted KO allele. Similar results,
confirming exon 2 deletion, were observed in skin, bone marrow and lung from KO mice. E–O: phenotyping. E–H, mouse photographs. E and F,
Female HF control and KO, respectively, 4 months after tamoxifen treatment. G: Three KO and one HF control female mice 9 months after tamoxifen
treatment. H: Male KO mouse 9 months after tamoxifen treatment.
doi:10.1371/journal.pone.0047196.g001
Mouse Mitochondrial Fatty Acid Synthesis Knockout
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and is not usually observed in normal mice until after the age of 18
months [28]. The failure to thrive could not be attributed to
inadequate food intake for, surprisingly, the KO mice ate
significantly more food than the HF controls, when normalized
for body weight (Fig. 2 panel C). Neither could the condition be
ascribed to a defect in digestion, since the protein and lipid content
of the feces was not significantly different in the two groups
(Table 1). Although grip strength of the KO mice was significantly
lower than that of HF controls (Fig. 2, panel D), the KO mice
performed as well as the HF controls on the accelerating rotarod,
which assesses motor coordination and balance for a short interval,
typically 1–2 minutes for each of three tests (Fig. 2, panel E).
However, when the rotarod was maintained at constant 5 rpm, in
a procedure designed to assess endurance, the KO mice fared less
well (these experiments were performed only with female mice).
HF control mice were able to complete 3 hours on the device
without difficulty, averaging only one fall every 144 min, and
remained lively at the end of the experiment. In contrast, KO mice
quickly became exhausted and fell repeatedly, necessitating
termination of the experiment after 15 min. Thus while balance
and motor coordination appear unaffected by the knockout,
stamina was considerably reduced. When evaluated singly in a
spontaneous-activity open field test, the KO mice were less
inclined to explore the environment and adopted the inquisitive
rearing posture less frequently than did the HF control mice.
Many of the KO mice walked with splayed rear legs and dragged
their posterior on the ground. Shivering was commonly observed.
Overall activity of the KO mice in the open field test was much
lower than HF controls (Fig. 2, panel F). When placed in an open
field as a group, HF control mice immediately separated and
began investigating the area. In contrast, the KO mice showed no
interest in exploring their environment and remained huddled
together, as if seeking warmth and indeed body temperature
measurements confirmed that these KO mice suffered from
hypothermia (Fig. 2, panel G). KO mice of either sex that were not
treated with tamoxifen did not develop any of the phenotypic
changes described above.
A survey of the literature on the use of the tamoxifen-inducible
B6.Cg-Tg(cre/Esr1)5Amc/J strain in the absence of a floxed
target-gene did not uncover any reports of long-term phenotypic
changes resembling those identified in our study. Thus, in order to
minimize the number of animals required for the study, we
considered it unnecessary to include mice carrying the Cre gene
but lacking the floxed Mcat gene. It has been reported that
tamoxifen administration to mice carrying the inducible Cre can
lead to transient cardiomyopathy and changes in energy metab-
olism, even in mice lacking a floxed transgene [29]. However, this
condition is fully reversible within one month of tamoxifen
withdrawal. Since the phenotypic changes observed in our KO
mice were observed only after tamoxifen-treatment, were not
evident until several months after cessation of tamoxifen treatment
and were persistent for the lifespan of the animals, we can
confidently attribute the changes specifically to the disruption of
the Mcat gene.
Necropsy and histology findings: KO mice loose white
adipose fat
The most conspicuous feature of the phenotype revealed by
gross examination at necropsy was the almost complete absence of
white adipose tissue by 7 months post-tamoxifen treatment.
Indeed mature visceral and subcutaneous white adipose could only
be identified on histological examination. In contrast, there was no
significant loss of brown adipose tissue (Fig. S2), which plays an
important role in thermogenesis rather than energy storage and
originates from a different cell lineage than does white adipose
[30]. With the exception of the spleens of a sub-population of KO
mice, which were considerably larger than those of control HF
mice, there was no statistically significant difference in absolute
weights of other organs between KO and HF mice (Fig. S2).
Histological examination of skin removed from KO mice by
biopsy revealed a severely depleted subcutaneous adipose layer as
well as hyperkeratinization (Fig. 3). It is well recognized that
cycling of the hair follicle through phases of intense mitotic activity
(anagen), regression (catagen) and dormancy (telogen) is accom-
panied by expansion and contraction of the subcutaneous adipose
layer. New evidence indicates that adipose precursor cells within
the dermal fat layer are directly responsible for driving activation
of follicular stem cells and induction of the anagen phase, probably
by the expression and secretion of platelet-derived growth factor
[31]. Other studies have uncovered a correlation between atrophy
of subcutaneous adipose tissue and hair loss [32,33]. Although we
cannot rule out the possibility that specific biochemical defects in
hair follicles and/or sebaceous glands contribute to hair loss, it
seems plausible that in our KO mouse model, the loss of
subcutaneous fat plays a role in the development of alopecia.
Clearly, loss of the insulation normally afforded by both hair and
subcutaneous adipose must place an additional burden on the
energy requirements of the KO mice and contribute to the
development of hypothermia.
We did not notice any unusual morphologic changes in muscle,
bone, or connective tissue in the spinal column, or hind limbs that
might account for the observed kyphosis, poor posture or
abnormal gait of the KO animals. Nevertheless, it remains
possible that subtle changes may have occurred that were not
readily apparent in routine sections stained with Hematoxylin and
Eosin.
A subpopulation of knockout mice develop rectal
prolapse and anemia
Twenty percent of male and 30% of female KO mice were
anemic, exhibiting elevated red blood cell distribution widths, low
hemoglobin levels, low red cell counts, increased mean corpuscu-
lar volume and elevated reticulocyte levels (Fig. 4, A–E).
Reticulocytes derived from anemic KO mice were larger than
were those from non-anemic KO and HF control mice as is
typically found when intense stimulation of erythropoiesis results
in the premature release of ‘stress’ reticulocytes into the circulation
[34]. In contrast, only minor differences were observed in white
cell levels between KO and HF control mice (Table S1). Analysis
of peripheral blood smears from anemic KO mice confirmed the
presence of enlarged red blood cells and also revealed the presence
of codocytes. These abnormal erythrocytes typically result from a
decreased content of hemoglobin that manifests as a pallid ring
flanking central and peripheral hemoglobinized zones (Fig. 4,
panel F). The anemic KO mice corresponded to the subpopula-
tion exhibiting enlarged spleens (Fig. S2) and showed evidence of
lymphoid atrophy and prominent extramedullary hematopoiesis.
Predominantly myeloid hematopoiesis was noted in the bone
marrow from anemic KO mice. Siderocytes, which contain iron
granules not associated with hemoglobin and can be indicative of
abnormal erythropoiesis, were absent from spleen and bone
marrow in these mice.
Nine of the ten anemic mice also developed severe rectal
prolapse, a condition not observed in either the non-anemic KO
or HF control animals (Fig. 4, panel G). Histological examination
of the prolapse revealed signs of neutrophil invasion and
inflammation (details not shown). Replacement of bedding with
filter paper revealed blood spots originating from the prolapsed
Mouse Mitochondrial Fatty Acid Synthesis Knockout
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anemic KO mice but not from either the non-anemic KO or HF
control animals (Fig. 4, panel H). We were unable to detect blood
in feces from prolapsed anemic KO mice indicating that the blood
spots originated from the inverted rectum. Biotin labeling
experiments revealed that the lifespan of red cells was reduced
in the anemic KO mice (Fig. 4, panel I). Based on the calculated
half-lives of 7.5 d and 18 d for red cells in the anemic KO and HF
control mice, respectively, and assuming that blood volume
amounts to ,7% of body mass, we calculated that the loss of
red cells in the prolapsed, anemic mice exceeded that expected
from normal turnover by ,60 mL per day. There was no evidence
of erythrophagocytosis in any tissue that might indicate increased
removal of defective or senescent erythrocytes; neither were
plasma bilirubin levels elevated in the anemic KO mice (Fig. 4,
Figure 2. Characteristics of the Mcat knockout mouse. A and B: mean relative body weights of 13 KO and 13 HF control male mice, initial
weights 21.662.5 g and 22.962.5, respectively (A) and 10 KO and 10 HF control female mice, initial weights 20.863.2 g and 19.063.2 g, respectively
(B). Asterisks indicate the earliest time points at which statistically significant differences in weight were observed. C: Mean food consumption
monitored for a 2-week period 7 months after tamoxifen treatment (11–13 measurements each group). D: mean grip strength of male, 5 KO and 7 HF
control, and female, 6 KO and 5 HF control mice. E: Mean residence times on the accelerating rotarod, measured 7 months post-induction, were not
significantly different between KO (14 male, 18 female) and HF controls (10 male, 25 female). F: Physical activity in the Open Field Test, assessed 7–8
months after tamoxifen treatment, in KO (12 male, 7 female) and HF controls (10 male, 9 female). G: Rectal body temperatures monitored in the
period 14–29 weeks after tamoxifen treatment (9 KO males and 7 KO females combined, 3 HF males and 8 HF females combined; 7 measurements for
each mouse) and in the period 36–45 weeks post-treatment (sexes shown separately, 2–3 measurements each mouse). Statistical significance in the
T-test, where observed, is indicated by *p.0.05, **p,0.005 or ***p,0.0005.
doi:10.1371/journal.pone.0047196.g002
Mouse Mitochondrial Fatty Acid Synthesis Knockout
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panel J), as would be expected for a hemolytic anemia. Thus the
anemia likely results primarily from chronic blood loss. Indeed
mice subjected to repeated bleeding develop a macrocytic anemia
similar to that described here [35]. Nevertheless, since red blood
cell distribution width, a parameter that normally rises with age
and is a strong predictor of mortality in humans [36], is greater in
both anemic and non-anemic KO mice than in HF mice, we
cannot unequivocally rule out the possibility that a defect in
erythropoiesis also contributes to the anemia.
Knockout mice have elevated plasma lactate and ketone
bodies
Blood chemistry analysis revealed that none of the markers for
liver function (alkaline phosphatase, alanine amino transferase,
aspartate amino transferase and bilirubin), kidney function (blood
urea nitrogen, creatinine and electrolytes) or pancreatic function
(amylase) were significantly altered in the KO mice (Table 1).
Although some differences were observed in blood lipid content
between KO and HF mice, they were not statistically significant
and all values fell within the range typically reported in the
literature for normal mice. Nevertheless, several blood chemistry
parameters were significantly elevated in KO animals, namely
lactate, ß-hydroxybutyrate and glucose, although the range of
glucose concentrations was far broader in the KO group (53–
656 mg/dL) than in the HF group (121–284 mg/dL). Lactate
levels were also significantly elevated in skeletal muscle from KO
mice. There were no significant differences in any of the blood
chemistry parameters between the sexes. In contrast to the
dramatic loss of fat reserves, glycogen stores were not depleted in
the KO mice; in fact the skeletal muscle glycogen levels were
higher in the KO compared to HF animals. These observations
indicated that the flux of glucose and gluconeogenic precursors
into glycogen was not impaired in KO mice.
Compromised fatty acid synthesis reduces availability of
precursors for lipoylation of key mitochondrial enzymes
The failure of KO mice to thrive, despite the ingestion of more
food than control animals, their loss of white adipose fat, the
development of hypothermia and elevated plasma lactate and ß-
hydroxybutyrate suggested that their metabolic efficiency was
compromised by the genetic defect induced in Mcat. Given the
earlier finding that the mitochondrial pathway for fatty acid
Table 1. Analysis of fecal, plasma and tissue composition.
Source Parameter Control KO
Feces Lipid, % dry weight 3.260.2 (4) 3.260.4 (4)
Protein, % dry weight 9.761.8 (4) 10.261.4 (4)
Plasma Sodium, mM 146.564.2 (6) 15569.1 (6)
Potasium, mM 7.4362.10 (6) 6.2561.42 (6)
Chloride, mM 107.264.2 (6) 12166.7 (6)**
Calcium, mg.dL21 10.361.15 (6) 9.9361.04 (6)
Phosphorus, mg.dL21 9.8562.19 (6) 11.664.0 (6)
Total Protein, g.dL21 5.7560.72 (6) 5.161.08 (6)
Albumin, g.dL21 3.4060.39 (6) 3.3060.59 (6)
Glucose, mg.dL21 187645 (11) 2786107 (20)**
Lactate, mM 13.366.1 (14) 20.067.8 (19)*
ß-hydroxybutyrate, mM 0.1560.07 (8) 0.3460.14 (13)**
Glycine, mM 243688 (3) 4656148 (3)
Proline, mM 129643 (3) 4146195 (3)
Urea Nitrogen, mg.dL21 25.363.8 (6) 35.1612.9 (6)
Creatinine, mg.dL21 0.11260.032 (6) 0.1060.037 (6)
Total Bilirubin mg.dL21 0.11560.018 (6) 0.10760.040 (7)1
Alkaline Phosphatase U/L 63.4614.6 (6) 91.6664.0 (6)
Alanine Aminotransferase U/L 121.0662.5 (6) 54.7613.9 (6)*
Aspartate Aminotransferase U/L 2256195 (6) 2736207 (6)
Amylase, U/L 353061450 (6) 34366590 (6)
Cholesterol, mg.dL21 165664 (6) 115628 (6)
Triglyceride, mg.dL21 117666 (6) 68.6657.1 (6)
Liver Glycogen, mg.g21 26.268.2 (8) 21.068.3 (9)
Skeletal Muscle Glycogen, mg.g21 1.0860.34 (6) 1.6860.40 (5)*
Lactate, mmol.g21 0.4060.2 (5) 6.660.4 (7)**
Values for plasma glucose and lactate and for fecal compositions were pooled from males and females; there was no significant difference in these values between the
sexes. All other values were obtained from male mice.
1Two of the seven KO mice were anemic with prolapsed rectums and had bilirubin levels of 0.07360.056. The five non-anemic KO mice had bilirubin levels of
0.1260.027. Statistically significant differences are noted:
*p,0.05,
**,0.005.
doi:10.1371/journal.pone.0047196.t001
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synthesis can supply the octanoyl precursor required for
posttranslational lipoylation of key mitochondrial proteins in-
volved in the citric acid cycle [9,10], we sought evidence as to
whether the energy disequilibrium might be attributable to a
defect in the mitochondrial protein lipoylation pathway.
Using quantitative Western blotting, we first established that
Mcat, as well as ß-ketoacyl synthase (Oxsm), another enzyme
required for the mitochondrial fatty acid biosynthetic pathway, is
expressed broadly in tissues of HF control mice (Fig. 5, panel A
and B). In contrast, we found that expression of LipT1, the lipoyl
transferase required for the alternative lipoylation pathway that
utilizes exogenous free lipoate, was limited mainly to liver (Fig. 5,
panel C). Compared to HF controls, KO mice that had been
treated with tamoxifen displayed significantly reduced abundance
of Mcat in all tissues examined (Fig. 5, panel D) but no change in
the relative abundance of LipT in any tissue (data not shown). The
most effective Mcat knockdown was observed in skeletal muscle,
where the residual levels were less than 1% of those found in HF
controls, and in heart and kidney. The relative abundance of
Oxsm, a mitochondrial matrix protein, and prohibitin, a
mitochondrial inner-membrane protein, was unaffected by the
knockout (Fig. 4 panel D), neither was the yield of mitochondria
from various tissues significantly different in the HF and KO mice
(details not shown). In addition, the fatty acid composition of
kidney mitochondria from KO mice, was found to be very similar
to that from HF mice (Fig. S3), despite the effective knockdown of
Mcat. The profile of mitochondrial lipid classes was also quite
similar, with the exception that cardiolipin levels appear to be
elevated in the KO animals (Fig. S3).
The lipoylation status of components of the mitochondrial
lipoamide subproteome subproteome was assessed using antibod-
ies directed toward the lipoyl moiety [10]. The lipoylation status of
the E2 subunits of PDC and BCDC was affected to variable
extents in different tissues; skeletal muscle and kidney suffered the
greatest decrease in the abundance of these lipoylated proteins
(Fig. 5, panel E). The lipoylation state of the H protein of the
glycine cleavage system was also reduced in tissues from the KO
mice but the levels were too low to be quantitated reliably by
Western analysis (details not shown). Plasma glycine concentra-
tion, which is elevated in glycine cleavage system deficiency in
humans [37], was also marginally higher in the KO compared to
HF mice (Table 1; T-test p value 0.1).
Since the lipoylated E2 subunit of KDC is not recognized by the
anti-lipoyl antibodies [10], we assayed the activity of this enzyme
directly and found that it too was reduced most effectively by the
knockout in skeletal muscle and kidney (Fig. 5. Panel F).
Measurement of PDC enzyme activity in skeletal muscle of the
KO mice (22.6% of the HF values) showed a good correlation with
the extent of the lipoylation knockdown (24.9% of the HF values).
Finally we assessed the effect of the Mcat knockdown on the fatty
acid biosynthetic capacity of mitochondria, using [2-14C] malo-
nate as substrate. The ability of mitochondria to synthesize
octanoyl-ACP, the major product of the pathway, was reduced by
more that 80% in organelles obtained from kidney and skeletal
muscle of KO mice, compared to HF controls (Fig. 5, panel G),
consistent with the observation that these tissues have a severe
knockdown of Mcat and exhibit a marked lipoylation defect.
Mitochondrial respiration is compromised by defects in
both protein lipoylation and respiratory complexes
Defective lipoylation of PDC and KDC would be expected to
limit the ability of mitochondria to respire using these substrates,
and indeed respiration on a-ketoglutarate and pyruvate/malate
was decreased significantly in mitochondria isolated from skeletal
muscle of KO compared to HF mice 200–240 days following
tamoxifen treatment (Fig. 6, panel A). Unexpectedly, succinate-
driven respiration was also decreased in the KO animals,
suggesting the presence of an additional deficit in these
mitochondria. Since succinate is metabolized by a non-lipoylated
enzyme, succinate dehydrogenase, we asked whether the deficit
might result from additional defects in the electron transport
chain. Spectral analysis indicated that there was ,40% reduction
in the amount of cytochrome a, the redox center of complex IV
(cytochrome c oxidase), in skeletal muscle mitochondria from KO
mice (Fig. 6, panel B). To assess the effect of this decrease on
complex IV activity, we determined the cyanide concentration
needed to inhibit complex IV in order to simulate the degree of
cytochrome a depletion observed in the KO. This cyanide
concentration was then used to quantify the effect of cytochrome
a depletion on state 3 respiration employing ketoglutarate,
pyruvate/malate, and succinate/rotenone as substrates. The
results (Fig. 6, panel C) revealed that the degree of inhibition of
respiration driven by succinate/rotenone was not significantly
different in mitochondria from KO mice and control mice that
had been depleted of cytochrome a. Thus the cytochrome a
depletion evident in mitochondria from KO mice could account
for the decreased respiration with succinate. In contrast, the
decreased respiration rate in mitochondria from KO mice
observed with either ketoglutarate or pyruvate/malate as sub-
strates could not be accounted for by the simulated cytochrome a
depletion. Thus, these effects can be attributed to defective
Figure 3. Skin Histology. Dorsal skin sections from HF control (A)
and KO (B) mice were fixed, paraffin embedded, sectioned at 10 mm and
stained with Hematoxylin and Eosin; bar, 100 mm.
doi:10.1371/journal.pone.0047196.g003
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Figure 4. Characterization of anemic KO mice. Approximately 20% of the KO mice were found to be anemic. A–E: blood cell analysis. A: Red
blood cell distribution width. Anemic KO mice (5 males and 5 females) were distinguished from non-anemic KO (20 males and 11 females) and HF
control (10 males, 9 females) on the basis of lower hematocrit (panel B), lower hemoglobin level (panel C), enlarged red cells (panel D) and elevated
reticulocyte levels (panel E). **Significantly different (p,0.05) from non-anemic KO and HF control mice; *significantly different from HF controls.
None of the parameters were significantly different between male and female KOs. No major differences were seen in other blood cell components.
The complete blood count analysis is presented as Table S1. F: Wright’s-stained blood smears from anemic KO and HF control male mice. Green
arrows indicate enlarged erythrocytes, black arrows codocytes. G: Rectal prolapse in KO female, 9 months post-induction; 9 of the 10 anemic mice
exhibited rectal prolapse. H. Blood spots on cage floor blot (,90660) obtained by 5 min exposure to 3 anemic mice with rectal prolapse; no blood
spots were observed on blots from cages housing non-anemic KO or HF mice. I: Red cell turnover study performed on 2 anemic KOs and 4 HF control
female mice. The two anemic mice had reticulocyte levels of 13.4 and 20.2%. J: Plasma bilirubin levels in HF (n = 6), non-anemic KO (n= 5) and anemic
KO (n = 2) mice; differences between groups were not statistically significant.
doi:10.1371/journal.pone.0047196.g004
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lipoylation of KDC and PDC. Western analysis of representative
subunits from each of the five respiratory complex also revealed
lower levels of complexes I, II and IV, although with marginal
statistical significance in some cases (Fig. 6, panel D, left).
Collectively, these findings indicate that defects in respiratory
chain complexes could contribute to the lower respiratory function
of mitochondria in skeletal muscle from the KO mice. Knockdown
of the mitochondrial pathway for fatty acid synthesis in yeast also
has been observed to result in defective assembly of respiratory
complexes but the mechanism is unknown [38,39,40]. So, how
significant are these secondary effects on the electron transport
chain in skeletal muscle mitochondria likely to be in the
development of the overall phenotype? Firstly, the deficit in
respiratory chain complexes is not universal in tissues of the KO
mice since no significant changes were observed in kidney
mitochondria (Fig. S4). Secondly, within 100 days of tamoxifen
treatment, maximum knockdown of the targeted Mcat is achieved
and the lipoylation defect is well established (details not shown). At
this stage, the mice are significantly smaller than the HF controls
(Fig. 2 panels A and B) and already have visible hair loss (Fig. 1
panel F). However no changes in the components of the electron
transport chain were apparent by Western blot at this stage (Fig. 6,
panel D, right). Thus, the delayed appearance of the defects in the
electron transport chain observed in skeletal muscle may
exacerbate the severity of the mature knockout phenotype but is
unlikely to play a role in the initial development of the phenotype.
Heart-specific knockout of Mcat is benign
We also engineered a second transgenic mouse model, replacing
mice of the B6.Cg-Tg(cre/Esr1)5Amc/J strain with B6129-
Tg(Myh6-cre/Esr1)1Jmk mice, in order to produce an Mcat
knockout restricted to heart muscle. These mice exhibited a similar
level of Mcat knockdown and compromised protein lipoylation in
heart as described for the ubiquitous Mcat KO mice, except that
no Mcat knockdown was observed in other tissues. These mice had
normal appearance and were indistinguishable from the HF mice,
according to the general parameters described in Figs. 1 and 2,
and were not subjected to any additional testing.
Conclusions
The most striking characteristic of the Mcat-knockout pheno-
type is the energy disequilibrium. Affected mice consume more
food than control animals, yet they fail to gain weight and are less
physically active, they have reduced muscle strength and stamina,
they eventually lose all of their white adipose tissue, develop
alopecia and kyphosis, loose weight and have a shortened lifespan.
Despite their retention of normal brown adipose tissue depots and
their shivering behavior, the KO mice are unable to maintain
normal body temperature. Biochemical analyses strongly suggest
that the primary factor responsible for development of this
phenotype is a diminished capacity of tissues such as skeletal
muscle to process the products of glycolysis and fatty acid
oxidation through the citric acid cycle. Thus the KO animals
have elevated levels of skeletal muscle lactate, blood lactate and
ketone bodies. The mitochondrial pathway for fatty acid synthesis
appears dedicated to the production of octanoyl moieties, the
lipoyl precursor, and has limited ability to form longer-chain acyl
moieties [3,9]. Consistent with this concept, failure of the pathway,
though knockout of the Mcat gene, manifests primarily as a
lipoylation defect, rather than as altered mitochondrial fatty acid
composition. The amounts of the catalytically-active lipoylated
forms of all four components of the mitochondrial lipoamide
subproteome, the E2 subunits of the PDC, KDC and BCDC
dehydrogenases, and the H-protein component of the glycine
cleavage system (GCSH) are reduced in tissues of KO mice, most
notably in skeletal muscle and kidney. These results indicate that
the de novo pathway for generation of lipoyl moieties is vital for
normal energy metabolism.
Prior to the discovery of this pathway it was generally assumed
that in mammals lipoyl moieties employed in the posttranslational
modification of mitochondrial proteins were derived from free
lipoate, which is first activated to lipoyl-AMP and then transferred
to the lysine acceptor residue at the lipoylation site. The two
enzymes required for this process, a lipoate activating enzyme and
lipoyl transferase (Lipt1) have been characterized from bovine liver
mitochondria [11,12]. In contrast, the de novo pathway operates
through different intermediates: an octanoyl moiety is translocated
from thioester linkage on the ACP to the lysine residue on the
acceptor protein, where the two sulfur atoms are subsequently
introduced by lipoic acid synthase (Lias). Although this enzyme has
yet to be characterized in mammals, a constitutive knockout of the
Lias gene in mice was found to be lethal in early embryonic
development [41]. Furthemore, downregulation of the pathway
for mitochondrial fatty acid synthesis in human cell culture
compromised the protein lipoylation pathway and resulted in cell
death [10]. Lipoate supplementation of the diet fed to the
pregnant mother did not rescue the knockout mouse embryos
neither did lipoate supplementation of the culture medium
improve survival of cultured HEK293 cells [10,41]. These
findings, together with the observation that the Mcat-deficient
mice exhibit a lipoylation defect, raise the question as to why, with
two independent pathways available for protein lipoylation, down-
regulation of the de novo pathway is not compensated for by the
utilization of free lipoate. The answer appears to be that, whereas
the enzymes required for the de novo pathway are expressed
broadly in many different tissues, the lipoyl transferase required for
the free lipoate pathway is expressed predominantly in the liver
and is not inducible in either liver or extrahepatic tissues when
Mcat is compromised. Although we did not attempt rescue of the
Mcat-deficient phenotype by lipoate supplementation, in view of
the earlier failure of this approach in other model systems it seems
likely that restricted expression of the Lipt1 limits the ability of the
lipoate scavenging pathway to service universally the components
of the mitochondrial lipoamide subproteome.
As is the case with many inducible gene knockout animal
models, the tamoxifen-induced ablation of the Mcat gene is
incomplete so that the residual enzyme expression ranges from
Figure 5. Content and enzyme activity of mitochondrial proteins. A: typical Western blots of mitochondrial proteins illustrating knockdown
of Mcat (row 1), lipoylation status of the E2 subunits of PDC and BCDC (rows 2 and 3, respectively), and the content of Oxsm, as a control (row 4). B
and C: Expression profiles of Mcat (B) and LipT (C) compared to controls, Oxsm and prohibitin, in mitochondria of HF control mice. The abundance of
the proteins is expressed relative to that of liver, which is assigned value of 1.0 (B, n = 2–6; C, n = 1–4). D: Abundance of Mcat and control proteins in
mitochondria from KO mice (n = 3–7) relative to the content in HF mice (n = 2–6). E: Lipoylation status of the E2 subunits of PDC and BCDC in KO mice
(n = 3–7) relative to HF controls (n = 2–6); mean assigned value of 1.0. F: Activities of KDC and PDC in mitochondria isolated from HF (n, 3–8) and KO
mice (n, 4–10). G: Overall activity of the mitochondrial fatty acid synthesis pathway, reported as production of octanoyl-ACP from malonate (n = 2, HF
and KO).
doi:10.1371/journal.pone.0047196.g005
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0.2% in skeletal muscle to 53% in spleen. Additionally, as
discussed above, in some tissues the Mcat defect results in only
mildly compromised protein lipoylation so that the phenotypic
changes observed in the Mcat knockout model are milder than
would be anticipated for a general, constitutive knockout.
Retention of some protein lipoylation capacity in tissues such as
liver also allows for further metabolism of lactate and ketone
bodies released from tissues that are compromised by a severe
lipoylation defect. Consequently, the effects of the Mcat knockout
are less grave than total knockouts of components of the
mitochondrial lipoamide subproteome, which can lead to severe
neurological and cardiac defects [42,43,44,45]. Mutations in
components of the mitochondrial pathway for fatty acid synthesis
that produce a lethal null phenotype, as observed in the knockout
of mouse Lias, the terminal enzyme in the de novo pathway for
protein lipoylation, are unlikely to manifest as disease in the
human population. Therefore, one can argue that the hypomor-
phic phenotype observed with the inducible Mcat knockout
represents a more useful model for predicting the consequences
of a non-lethal defect in the pathway in the human population. In
the Mcat KO model, the degree of Mcat knockdown and
compromised protein lipoylation is particularly severe in skeletal
muscle. Indeed, muscle weakness and poor posture is a readily
recognizable characteristic of the phenotype and may play a role
in the development of both kyphosis, through weakening of the
paraspinal muscle [46], and rectal prolapse, through weakening of
muscles of the anal sphincter and those that hold the rectum in
place [47].
Because of the crucial role played by the citric acid cycle in
energy metabolism, the primary defect in lipoylation of PDC and
KDC resulting from the deficiency in Mcat in some tissues may
initiate a cascade of secondary effects that could contribute to the
phenotype. In skeletal muscle, where the lipoylation pathway is
severely effected, a compromised citric acid cycle could limit the
availability of citrate for export into the cytosol where it provides
the acetyl-CoA required for de novo fatty acid synthesis via the
type I fatty acid synthase. Triglycerides synthesized and stored in
muscle cells are now recognized as an important fuel for muscle
activity during exercise [48]. Other less predictable secondary
effects, such as the observed late-developing depletion of
Figure 6. Respiratory properties of skeletal muscle mitochondria. A: Oxygen consumption by mitochondria isolated from mice 8–9 months
following treatment with tamoxifen. Values are means 6 SEM (n= 4). ‘‘State 3’’ indicates respiration rates during ATP synthesis, ‘‘State 4’’ is in the
presence oligomycin to inhibit ATP synthesis, and ‘‘uncoupled’’ is in the presence of carbonyl cyanide p-[trifluoromethoxy]phenylhydrazone to
measure maximal respiration rates. The uncoupled rate with a-ketoglutarate is low because the enzyme was depleted of ADP, its allosteric activator;
additional data (not shown) demonstrated that addition of ADP increased the uncoupled rate. B: Cytochrome content: values are means 6 SEM
(n = 5). C: Respiration of mitochondria treated with NaCN. NaCN (15 mM) was added to control mitochondria to mimic the 40% reduction in
cytochrome oxidase observed in mitochondria from KO compared to control mice. Respiration, measured in the presence of ketoglutarate,
pyruvate+malate, and succinate+rotenone, was compared with that of untreated mitochondria from KO mice. D: Abundance of subunits of the five
respiratory chain complexes in mitochondria from KO (n= 3) relative to HF control (n = 4) mice. Western blotting was used to detect subunits of
complexes I (NDUFB8), II (30 kDa subunit), III (core protein 2), IV (subunit 1) and V (alpha subunit), employing primary antibodies obtained from
Mitosciences. The antigen targets represent labile subunits that are degraded when not assembled into the appropriate complex and thus are
representative of the abundance of the fully assembled complexes. Mitochondria were isolated from two groups of mice 8–9 months and 3–4
months following treatment with tamoxifen. Statistical significance in unpaired t-tests is indicated by *p.0.05 or **p,0.005; for p values of marginal
significance actual values are shown.
doi:10.1371/journal.pone.0047196.g006
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components of the electron transport chain in muscle, may also
contribute to the phenotype. Detailed evaluation of these
secondary effects resulting from the lipoylation defect in different
tissues was beyond the scope of this initial study. A summary
highlighting the features of the Mcat-deficient phenotype is
presented in Box 1.
Many of the phenotypic characteristics of the Mcat knockout
mouse model bear striking resemblance to those described in other
models of compromised mitochondrial function that have been
collectively termed as examples of accelerated aging. For example,
mice carrying a proofreading-deficient mitochondrial DNA
polymerase exhibit reduced lifespan, weight loss, reduced subcu-
taneous white adipose, alopecia, kyphosis and an age-dependent,
macrocytic anemia with abnormal erythroid maturation [33,49].
These phenotypic changes result primarily from an accumulation
of mutations in the mitochondrial genome that leads to loss of
respiratory chain function. Mice deficient in the mitochondrial
helicase SupvL1, a component of the mitochondrial RNA
degradosome complex, exhibit growth retardation, kyphosis,
thickening of the epidermis and atrophy of subcutaneous adipose
and muscle mass and early death [50]. In this case the phenotypic
changes most likely result from aberrant mitochondrial RNA
processing that leads to impaired protein synthesis and ATP
production. Recently, a mouse model with compromised mito-
chondrial superoxide dismutase exclusively in connective tissue has
been described that is also characterized by weight loss,
osteoporosis and kyphosis, skin abnormalities, muscle loss and
reduced lifespan [51]. In this model, the altered phenotype results
from oxidative damage in mitochondria and loss of redox balance.
Although it may seem remarkable that random mutations in
mitochondrial DNA, defects in the mitochondrial degradosome,
deficiency of mitochondrial superoxide dismutase and compro-
mised mitochondrial fatty acid synthesis precipitate a similar set of
phenotypic changes, this is one of the hallmarks of mitochondrial
diseases: different mutations in either the mitochondrial or nuclear
genomes can lead to similar diseases, known as phenocopies.
Several phenotypic features of these mouse models of accelerated
aging are also associated with aging in humans, particularly
osteoporosis, kyphosis, decreased muscle strength, loss of subcu-
taneous fat resulting in skin wrinkling and alopecia, prolapsed
rectum and weight loss, typically after age 60 years. The broad
range of mitochondrial defects that can lead to the accelerated
aging phenotype serves to illustrate the difficulty in establishing the
etiology of human diseases in which defective mitochondrial
function is implicated. The present study suggests that current
guidelines for the evaluation of patients of all ages with suspected
mitochondrial diseases [2] should be broadened to include the
possibility of compromised mitochondrial fatty acid synthesis and
protein lipoylation.
Supporting Information
Figure S1 Engineering of the Mcat knockout gene. A.
Overall strategy. A schematic of the targeting vector (i) showing
the locations of the Frt-flanked ß-geo cassette, lox sites, and both the
coding (black-filled rectangles) and non-coding (white-filled
rectangles) regions of the 4 exons. Targeted ES cells were
transfected with a Flp recombinase plasmid to excise the gene-
trapping cassette creating a ‘‘floxed’’ or conditional knockout allele
(ii). Chosen clones were injected into blastocysts, chimeric
offspring were identified and bred to homozygosity for the floxed
Mcat allele. These mice were bred with mice of the inducible-Cre
strain B6.Cg-Tg(cre/Esr1)5Amc/J. Mice homozygous for the the
floxed Mcat allele carrying a single copy of the Cre gene were
identified and treated with tamoxifen to generate a truncated Mcat
gene (iii). B. Annotated nucleotide sequence of the modified gene.
Boxed region: Exon 2. Green text lox71 (upstream) and loxP
(downstream) sites. Blue text: The single remaining Frt site after Flp
recombination. Pink text: Residual exogenous sequence from
construct engineering. Yellow highlight: Location of primer pairs
used for characterization of the Mcat alleles by the PCR. Pairs p5
(CGGTACTGATTACAACCATGAGCGG-CCATAG) and
pEx2 (AGCAACACAGTTGTCGATGA-CCTG) or p5 and p3
(CACTCAAGCTGGGT-GCTGAATAGGCTTTGCAA). The
Cre recombinase gene was detected using the PCR as recom-
mended by Jackson Labs.
(PDF)
Figure S2 Organ Weights. Weights of organs from KO mice
are expressed relative to those of HF control mice, both as gross
weights (blue) and after normalization for body weight (red).
Brown adipose is from the interscapular region. Abdominal fat
depots in KO mice were too small to be measured. The number of
measurements is shown in parenthesis for the HF and KO
animals, respectively. The statistical significance, where detected,
is indicated by * p,0.05, **p,0.005.
(PDF)
Figure S3 Analysis of kidney mitochondrial lipids.
Mitochondria were isolated from kidneys, obtained from male
KO (22.3 g) and HF (38.6 g) mice 8 months after treatment with
tamoxifen, purified by centrifugation on an iodixanol gradient
(fraction density ,1.13 g/mL) and frozen. Thawed mitochondria
were washed with 150 mM ammonium bicarbonate. Lipids were
extracted with chloroform:methanol (2:1) from portions equivalent
to 50 mg of mitochondrial protein and analyzed by mass
spectrometry, essentially as described earlier [52]. For analysis of
total fatty acid composition, mitochondrial lipids were methylated
by treating mitochondria with 2.5% H2SO4 in methanol for
1.5 hour at 85uC. Methyl esters were extracted with hexane and
analyzed by gas chromatography. Results are reported as mole %
distribution within each lipid class. The total amounts of fatty acid
recovered were 133 and 159 ng per mg protein for HF and KO
mice, respectively. The total amounts of each lipid class recovered
from the KO mouse relative to that from the HF mouse (assigned
a value of 1.0) were: cardiolipin, KO 2.060.4, HF 1.060.04;
lysophosphatidylinositol and phosphatidylinositol, KO, 1.360.2,
HF 1.060.01; lyso phosphatidylethanolamine and phosphatidyl-
ethanolamine, KO 1.0760.08, HF 1.060.02; phosphatidyl
choline, KO 1.360.0, HF 1.060.05; sphingomyelin, KO
0.6560.001, HF 1.060.1. Trace amounts of phosphatidyl serine
and phosphatidic acid were detected that were too low for
quantitation. Blue bars correspond to HF control values, red to
KO.
(PDF)
Figure S4 Abundance of subunits of the respiratory
chain complexes in kidney mitochondria. Western blotting
was used to detect subunits of complexes I (NDUFB8), II (30 kDa
subunit), III (core protein 2), IV (subunit 1) and V (alpha subunit)
as described in Figure 6D.
(PDF)
Table S1 CBC Analysis. **Significantly different (p,0.05)
from non-anemic KOs and HFs; *significantly different from HFs.
None of the parameters were significantly different between male
and female KOs.
(PDF)
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